covid-19 new research

COVID Antibodies Decline, But The Question About Lasting Immunity is Still Unanswered

Protective antibodies against COVID-19 may only last a short time after infection, new evidence shows. However, it doesn’t mean that scientists have definitively answered the question about lasting immunity for this particular virus. The current thinking is that even low levels of powerful neutralizing antibodies may still be protective – after all, the immune system…

Blood Pressure Medications Don’t Increase Risk for Severe COVID-According to New Wuhan Data Analysis

Potential good news for those with high blood pressure… taking antihypertensive medication, including ACE-inhibitors and ARBs, does not seem to increase the risk of more severe COVID-19 infection. This is based on a collective meta-analysis of group data from Wuhan, China reported in the European Heart Journal. This had previously been a potential concern since…

Scientific Papers Retracted from One of the World’s Most Prestigious Journals

Last week, the prestigious medical journal, The Lancet, retracted two COVID-19-related papers. One of those papers had reported on negative effects of hydroxycloroquine as a potential treatment option, leading to much controversy over the use of the drug. The reason for the retraction? Surgisphere Corporation, the company providing the underlying database of information that was…

Detecting Nutritional Deficiencies in Sweat – A New Possibility

Biosensors that provide realtime feedback on health-related parameters are considered profoundly useful tools for optimizing health status and encouraging adherence to healthier activities. A new wearable device now does this for vitamin C. The device contains the enzyme ascorbate oxidase, which on contact with vitamin C (ascorbic acid) changes the electrochemical current flow. Given the…

Inflammation resolution is a key strategy for escalating COVID-19 symptoms – a new paper and free DrKF webinar replay

From the folks that brought us Specialized Pro-resolving Lipid Mediators (SPMs), comes a new peer-reviewed paper that highlights the potential for SPMs in addressing pro-inflammatory cytokine production and cytokine storm in COVID-19. SPMs stimulate macrophage-mediated clearance of cellular debris and reduce pro-inflammatory cytokine levels. They also promote anti-viral B cell antibodies and other white blood…